Osaka, Japan

Kazuhiro Miwa

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 1.9

ph-index = 10

Forward Citations = 226(Granted Patents)


Location History:

  • Kyoto, JP (2009)
  • Osaka, JP (2007 - 2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations of Kazuhiro Miwa: A Pioneer in Thienopyrimidine Derivatives

Introduction

Kazuhiro Miwa, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceutical chemistry, particularly focusing on thienopyrimidine derivatives. With a total of 16 patents to his name, he has established himself as a leading innovator in developing high-quality production methods for these vital compounds.

Latest Patents

Among his recent patents, Miwa has introduced a production method for thienopyrimidine derivatives, which exhibit gonadotropin-releasing hormone (GnRH) antagonistic action. This innovative approach ensures a high yield and quality of the derivatives, which can play crucial roles in treating various conditions related to reproductive health. The method involves reacting specific chemical compounds, including 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, with reagents such as 1,1'-carbonyldiimidazole and methoxyamine.

Career Highlights

Kazuhiro Miwa is currently associated with Takeda Pharmaceutical Company Limited, where he works on developing advanced pharmaceutical solutions. His innovative research and dedication to improving production methods have greatly contributed to the company's portfolio of medicinal products. Miwa's expertise in synthetic organic chemistry has earned him recognition within the scientific community.

Collaborations

Throughout his career, Miwa has collaborated with notable colleagues, including Takashi Imada and Takenori Hitaka. These partnerships have proven essential in advancing their shared goals of research and development in pharmaceutical sciences, allowing for a fruitful exchange of ideas and expertise.

Conclusion

Kazuhiro Miwa's work exemplifies the spirit of innovation within the pharmaceutical industry. His patents on thienopyrimidine derivatives signify a crucial milestone in the development of effective treatments targeting reproductive health issues. As he continues to push the boundaries of scientific discovery, Miwa's contributions will undoubtedly have a lasting impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…